← back to search

Müge Çevik

University of St Andrews · GB
Area of research
Infectious Diseases · Modeling and Simulation
Research interest
Research interests include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, COVID-19 epidemiological studies, and Tuberculosis Research and Epidemiology.
h-index
45
citations
13,891
works
153
NIH funding
primary concept
Medicine
email

Recent publications

Beyond Parity: Gender Inequities and Recommendations in Infectious Diseases and Clinical Microbiology Research.
2026cited by 0position: contributordoi
How can health care professionals address vaccine hesitancy in practice?
2026cited by 0position: contributordoi
Gender differences in audience participation at infectious disease and microbiology conferences: a prospective observational study.
2026cited by 0position: contributordoi
Assessing mpox knowledge and sexual behaviours within high-risk populations in the Democratic Republic of the Congo
2025cited by 1position: contributordoi
Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trials
2025cited by 0position: contributordoi
Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trials.
2025cited by 0position: contributordoi
Gender of authors and editors in top-ranked infectious diseases journals: A longitudinal trend analysis
CMI Communications 2025cited by 0position: contributordoi
Clade I-Associated Mpox Cases Associated with Sexual Contact, the Democratic Republic of the Congo.
2024cited by 135position: contributordoi
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
2024cited by 42position: contributordoi
Clinical course and management of COVID-19 in the era of widespread population immunity.
2024cited by 35position: contributordoi
The 2023 – 2024 multi-source mpox outbreaks of Clade I MPXV in sub-Saharan Africa: Alarm bell for Africa and the World
International Journal of Infectious Diseases 2024cited by 24position: firstdoi
The 2023 – 2024 multi-source mpox outbreaks of Clade I MPXV in sub-Saharan Africa: Alarm bell for Africa and the World
IJID Regions 2024cited by 12position: firstdoi
The 2023 - 2024 multi-source mpox outbreaks of Clade I MPXV in sub-Saharan Africa: Alarm bell for Africa and the World.
2024cited by 12position: contributordoi
The 2023–2024 multi-source mpox outbreaks of Clade I MPXV in sub-Saharan Africa: Alarm bell for Africa and the World
IJID One Health 2024cited by 9position: firstdoi
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs.
2024cited by 3position: contributordoi
Gender and geographical representation at infectious diseases and clinical microbiology conferences.
2024cited by 1position: contributordoi
Predictable excess hepatotoxicity in the SimpliciTB trial - Authors' reply.
2024cited by 0position: contributordoi
Emergence of mpox in the post-smallpox era—a narrative review on mpox epidemiology
Clinical Microbiology and Infection 2023cited by 70position: middledoi
Emergence of mpox in the post-smallpox era-a narrative review on mpox epidemiology.
2023cited by 51position: contributordoi
Mpox virus and transmission through sexual contact: Defining the research agenda.
2023cited by 29position: contributordoi
Non-pharmaceutical interventions for COVID-19: a systematic review on environmental control measures.
2023cited by 8position: contributordoi
Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFs.
2023cited by 7position: contributordoi
Estimating the global impact of coronavirus disease 2019 on people living with HIV.
2023cited by 5position: contributordoi
In-person schooling is essential even during periods of high transmission of COVID-19.
2023cited by 5position: contributordoi
A multi-country analysis of COVID-19 hospitalizations by vaccination status.
2023cited by 3position: contributordoi
Changing face of mpox.
2023cited by 2position: contributordoi
A Systematic Review on the Effect of Diabetes Mellitus on the Pharmacokinetics of Tuberculosis Drugs
2023cited by 0position: contributordoi
Omicron variant: assessing the duration of viral shedding and its implications.
2023cited by 0position: contributordoi
Prevalence of COVID-19 infection in TB clinics in Kampala, Uganda.
2023cited by 0position: contributordoi
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
2022cited by 1,372position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 21 papers (2020–2026)Aleksandra Barać · University of Belgrade11 papers (2019–2021)Louise Sigfrid · Imperial College London7 papers (2020–2023)Nicola Low · Bern University of Applied Sciences7 papers (2020–2024)Chloe M. Orkin · Royal London Hospital6 papers (2019–2023)Peter Horby · Johns Hopkins Hospital6 papers (2020–2023)Tom Fletcher · University of Liverpool6 papers (2020–2023)David S. Y. Ong · Gelre Hospitals5 papers (2019–2020)Lance CW Turtle · Johns Hopkins Hospital5 papers (2020–2021)Ewen M. Harrison · Johns Hopkins Hospital5 papers (2020–2023)Antonia Ho · Johns Hopkins Hospital5 papers (2020–2021)Marc Lipsitch · Center for Disease Dynamics, Economics & Policy5 papers (2020–2021)Nicola Low · University of Bern4 papers (2023–2024)J Kenneth Baillie · University of Southampton4 papers (2020–2021)Xueting Qiu · Suzhou Municipal Hospital4 papers (2020–2022) · 4 papers (2021–2024)Simon Collins · Jet Propulsion Laboratory4 papers (2020–2021) · 3 papers (2024–2024)Edward Goldstein · Harvard University3 papers (2020–2021)Sharmistha Mishra · St. Michael's Hospital3 papers (2021–2022)